Nucleotide metabolism, oncogene-induced senescence and cancer
Open accessAbstract
Senescence is defined as a stable cell growth arrest. Oncogene-induced senescence (OIS) occurs when an activated oncogene is expressed in a normal cell. OIS acts as a bona fide tumor suppressor mechanism by driving stable growth arrest of cancer progenitor cells harboring the initial oncogenic hit. OIS is often characterized by aberrant DNA replication and the associated DNA damage response. Nucleotides, in particular deoxyribonucleotide triphosphates (dNTPs), are necessary for both DNA replication and repair. Imbalanced dNTP pools play a role in a number of human diseases, including during the early stages of cancer development. This review will highlight what is currently known about the role of decreased nucleotide metabolism in OIS, how nucleotide metabolism leads to transformation and tumor progression, and how this pathway can be targeted as a cancer therapeutic by inducing senescence of cancer cells.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
During OIS, fatty acid metabolism is altered, glucose consumption is enhanced, and utilization of pyruvate in the tricarboxylic acid cycle and nucleotide deficiency are increased.
“Moreover, during OIS, fatty acid metabolism is altered, glucose consumption is enhanced, and the utilization of pyruvate in the tricarboxylic acid cycle and nucleotide deficiency are increased [119,216,217,218,219].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [219]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · see citing works
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508 · see citing works
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · see citing works
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,178 · cited 2× · see citing works
“1), which contribute to the stable growth arrest [32].”
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · see citing works
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · see citing works
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,359 · see citing works
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317 · see citing works
Four faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,016 · cited 1× · see citing works
“Senescent cells have unique morphological and molecular characteristics [25].”
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · see citing works
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821 · see citing works
ATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798 · see citing works
Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386761a0 · Cited by 1,240 · see citing works
Oncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220 · see citing works
Nordlund, P., & Reichard, P. A. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142443 · Cited by 1,082 · see citing works
Links between metabolism and cancerPreprint
Dang, C. V. (2012) · Genes & Development · doi:10.1101/gad.189365.112 · Cited by 991 · see citing works
Nucleotide deficiency promotes genomic instability in early stages of cancer development
Bester, A. C., Roniger, M., Oren, Y. S., Im, M. M., Sarni, D., Chaoat, M., Bensimon, A., Zamir, G., Shewach, D. S., & Kerem, B. (2011) · Cell · doi:10.1016/j.cell.2011.03.044 · Cited by 858 · see citing works
INTERACTIONS BETWEEN DEOXYRIBONUCLEOTIDE AND DNA SYNTHESIS
Reichard, P. A. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.002025 · Cited by 773 · see citing works
Glutamine and glutamate—their central role in cell metabolism and function
Newsholme, P., Procópio, J., Lima, M. M. R., Pithon‐Curi, T. C., & Curi, R. (2002) · Cell Biochemistry and Function · doi:10.1002/cbf.1003 · Cited by 706 · see citing works
The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.Preprint
Hiebert, S. W., Chellappan, S., Horowitz, J. M., & Nevins, J. R. (1992) · Genes & Development · doi:10.1101/gad.6.2.177 · Cited by 576 · see citing works
Inhibition of E2F-1 Transactivation by Direct Binding of the Retinoblastoma Protein
Helin, K., Harlow, E. E., & Fattaey, A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6501 · Cited by 472 · see citing works
The Biological Significance of Purine Salvage
Murray, A. (1971) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.40.070171.004115 · Cited by 418 · see citing works
The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence
Mallette, F. A., Gaumont-Leclerc, M.-F., & Ferbeyre, G. (2007) · Genes & Development · doi:10.1101/gad.1487307 · Cited by 406 · see citing works
Alimonti, A., Nardella, C., Chen, Z., Clohessy, J. G., Carracedo, A., Trotman, L. C., Cheng, K., Varmeh, S., Kozma, S. C., Thomas, G., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40535 · Cited by 374 · see citing works
RecQ helicases: suppressors of tumorigenesis and premature aging
Bachrati, C. Z., & Hickson, I. D. (2003) · Biochemical Journal · doi:10.1042/bj20030491 · Cited by 372 · see citing works
Oncogene-Induced Cell Senescence — Halting on the Road to Cancer
Mooi, W. J., & Peeper, D. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062285 · Cited by 371 · see citing works
Finch, R. A., Liu, M., Grill, S. P., Rose, W. C., Loomis, R. H., Vásquez, K. M., Cheng, Y.-C., & Sartorelli, A. C. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00419-0 · Cited by 366 · see citing works
Flemington, E. K., Speck, S. H., & Kaelin, W. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.6914 · Cited by 348 · see citing works
Checking on the fork: the DNA-replication stress-response pathway
Osborn, A. J., Elledge, S. J., & Zou, L. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)02380-2 · Cited by 345 · see citing works
Dynamics of DNA Replication in Mammalian Somatic Cells
Anglana, M., Apiou, F., Bensimon, A., & Debatisse, M. (2003) · Cell · doi:10.1016/s0092-8674(03)00569-5 · Cited by 339 · see citing works
El‐Hattab, A. W., & Scaglia, F. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0177-6 · Cited by 336 · see citing works
DNA precursor metabolism and genomic stability
Mathews, C. K. (2006) · The FASEB Journal · doi:10.1096/fj.06-5730rev · Cited by 311 · see citing works
Håkansson, P., Hofer, A., & Thelander, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512894200 · Cited by 290 · see citing works
Aird, K. M., Zhang, G., Li, H., Tu, Z., Bitler, B. G., Garipov, A., Wu, H., Wei, Z., Wagner, S. N., Herlyn, M., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.004 · Cited by 285 · see citing works
Self-citationEngström, Y., Eriksson, S., Jildevik, I., Skog, S., Thelander, L., & Tribukait, B. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39337-7 · Cited by 285 · see citing works
Ribonucleotide Reductase Inhibitors and Future Drug Design
Shao, J., Zhou, B., Chu, B. W., & Yen, Y. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906777723949 · Cited by 284 · see citing works
Allegra, C. J., Paik, S. Y., Colangelo, L. H., Parr, A. L., Kirsch, I. R., Kim, G., Klein, P. M., Johnston, P. G., Wolmark, N., & Wieand, H. S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.044 · Cited by 282 · see citing works
DNA replication stress, genome instability and aging
Burhans, W. C., & Weinberger, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1059 · Cited by 279 · see citing works
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesisPreprint
Vredeveld, L. C. W., Possik, P. A., Smit, M. A., Meissl, K., Michaloglou, C., Horlings, H. M., Ajouaou, A., Kortman, P. C., Dankort, D. L., McMahon, M., et al. (2012) · Genes & Development · doi:10.1101/gad.187252.112 · Cited by 258 · see citing works
Weinberg, G. A., Ullman, B., & Martin, D. W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2447 · Cited by 228 · see citing works
Bianchi, V., Pontis, E., & Reichard, P. A. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66672-4 · Cited by 224 · see citing works
Finch, R. A., Liu, M., Cory, A. H., Cory, J. G., & Sartorelli, A. C. (1999) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(98)00017-x · Cited by 223 · see citing works
Meuth, M. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90090-6 · Cited by 219 · see citing works
Iron Chelators for the Treatment of Cancer
Yu, Y., Gutierrez, E., Kovačević, Ž., Saletta, F., Obeidy, P., Rahmanto, Y. S., & Richardson, D. R. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800609706 · Cited by 188 · see citing works
Bepler, G., Sharma, S., Cantor, A. B., Gautam, A., Haura, E. B., Simon, G. R., Sharma, A., Sommers, E., & Robinson, L. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.002 · Cited by 179 · see citing works
Thymidylate synthase as an oncogene
Rahman, L., Voeller, D. M., Rahman, M., Lipkowitz, S., Allegra, C. J., Barrett, J. C., Kaye, F. J., & Zajac‐Kaye, M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00080-7 · Cited by 179 · see citing works
The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer
Jordheim, L. P., Sève, P., Trédan, O., & Dumontet, C. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70244-8 · Cited by 164 · see citing works
Fujita, H., Ohuchida, K., Mizumoto, K., Itaba, S., Ito, T., Nakata, K., Yu, J., Kayashima, T., Souzaki, R., Tajiri, T., et al. (2010) · Neoplasia · doi:10.1593/neo.10458 · Cited by 154 · see citing works
Nutting, C. M., van Herpen, C. M. L., Miah, A. B., Bhide, S. A., Machiels, J.-P., Buter, J., Kelly, C., Raucourt, D. D., & Harrington, K. J. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn775 · Cited by 147 · see citing works
Zhang, Y., Jones, T. L., Martin, S. E., Caplen, N. J., & Pommier, Y. G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003020 · Cited by 146 · see citing works
RRM1-induced metastasis suppression through PTEN-regulated pathways
Gautam, A., Li, Z.-R., & Bepler, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206232 · Cited by 142 · see citing works
Kimura, T., Takeda, S., Sagiya, Y., Gotoh, M., Nakamura, Y., & Arakawa, H. (2003) · Nature Genetics · doi:10.1038/ng1212 · Cited by 141 · see citing works
Oncogene-Induced Senescence Pathways Weave an Intricate Tapestry
Yaswen, P., & Campisi, J. (2007) · Cell · doi:10.1016/j.cell.2007.01.005 · Cited by 138 · see citing works
Hydroxyurea: a key player in cancer chemotherapy
Madaan, K., Kaushik, D., & Verma, T. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.11.175 · Cited by 133 · see citing works
The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescencePreprint
Aksoy, O., Chicas, A., Zeng, T., Zhao, Z., McCurrach, M. E., Wang, X., & Lowe, S. W. (2012) · Genes & Development · doi:10.1101/gad.196238.112 · Cited by 127 · see citing works
Prognostic importance of thymidylate synthase expression in early breast cancer.
Pestalozzi, B. C., Peterson, H. F., Gelber, R. D., Goldhirsch, A., Gusterson, B. A., Trihia, H., Lindtner, J., Cortés-Funes, H., Simmoncini, E., Byrne, M., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1923 · Cited by 123 · see citing works
Nucleic Acids, Purines, Pyrimidines (Nucleotide Synthesis)
Hartman, S. C., & Buchanan, J. M. (1959) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.28.070159.002053 · Cited by 121 · see citing works
The Control of Nucleotide Biosynthesis
Blakley, R. L., & Vitols, E. (1968) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.37.070168.001221 · Cited by 120 · see citing works
Pharmacokinetics and Pharmacodynamics of Hydroxyurea
Gwilt, P. R., & Tracewell, W. G. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199834050-00002 · Cited by 115 · see citing works
New ribonucleotide reductase inhibitors with antineoplastic activity.
Elford, H. L., Wampler, G. L., & Riet, B. V. (1979) · PubMed · Cited by 114 · see citing works
DNA Replication Stress Is a Determinant of Chronological Lifespan in Budding Yeast
Weinberger, M., Li, F., Paul, A., Smith, D. L., Hontz, R. D., Smith, J. S., Vujcic, M., Singh, K. K., Huberman, J. A., & Burhans, W. C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000748 · Cited by 109 · see citing works
Ribonucleotide reductase inhibitors: new strategies for cancer chemotherapy
Nocentini, G. (1996) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(95)00187-5 · Cited by 108 · see citing works
Overview of Ribonucleotide Reductase Inhibitors: An Appealing Target in Anti-Tumour Therapy
Cerqueira, N. M. F. S. A., Pereira, S. R., Fernandes, P. A., & Ramos, M. J. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054020981 · Cited by 104 · see citing works
Laßmann, G., Thelander, L., & Gräslund, A. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91138-g · Cited by 102 · see citing works
Ddb1 controls genome stability and meiosis in fission yeastPreprint
Holmberg, C., Fleck, O., Hansen, H. A., Liu, C., Slaaby, R., Carr, A. M., & Nielsen, O. (2005) · Genes & Development · doi:10.1101/gad.329905 · Cited by 100 · see citing works
Fan, H., Huang, A., Villegas, C., & Wright, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13181 · Cited by 100 · see citing works
Liu, X., Zhang, H., Lai, L. L., Wang, X., Loera, S., Xue, L., Hui-yin, H., Zhang, K., Hu, S., Huang, Y., et al. (2012) · Clinical Science · doi:10.1042/cs20120240 · Cited by 94 · see citing works
Ribonucleotide Reductase: A Critical Enzyme for Cancer Chemotherapy and Antiviral Agents
Cerqueira, N. M. F. S. A., & Ramos, M. J. (2007) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489207779561408 · Cited by 93 · see citing works
Broad Overexpression of Ribonucleotide Reductase Genes in Mice Specifically Induces Lung Neoplasms
Xu, X., Page, J. L., Surtees, J. A., Liu, H., Lagedrost, S. J., Lu, Y., Bronson, R. T., Alani, E., Nikitin, A. Y., & Weiss, R. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5873 · Cited by 91 · see citing works
Kunos, C. A., Radivoyevitch, T., Waggoner, S. E., Debernardo, R., Zanotti, K. M., Resnick, K. E., Fusco, N. L., Adams, R., Redline, R. W., Faulhaber, P., et al. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.04.019 · Cited by 87 · see citing works
CHABOSSEAU, P. L., Buhagiar‐Labarchède, G., Onclercq, R., Lambert, S., Debatisse, M., Brison, O., & Amor-Guéret, M. (2011) · Nature Communications · doi:10.1038/ncomms1363 · Cited by 84 · see citing works
Mannava, S., Moparthy, K., Wheeler, L. J., Natarajan, V., Zucker, S. N., Fink, E. E., Im, M. M., Flanagan, S. A., Burhans, W. C., Zeitouni, N. C., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.09.011 · Cited by 83 · see citing works
Attia, S., Kolesar, J., Mahoney, M. R., Pitot, H. C., Laheru, D. A., Heun, J. M., Huang, W., Eickhoff, J. C., Erlichman, C., & Holen, K. D. (2008) · Investigational New Drugs · doi:10.1007/s10637-008-9123-6 · Cited by 81 · see citing works
Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics
Pitceathly, R. D. S., Smith, C., Fratter, C., Alston, C. L., He, L., Craig, K., Blakely, E. L., Evans, J., Taylor, J. M., Shabbir, Z., et al. (2012) · Brain · doi:10.1093/brain/aws231 · Cited by 81 · see citing works
Rothmund–Thomson syndrome and RECQL4 defect: Splitting and lumping
Larizza, L., Magnani, I., & Roversi, G. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.042 · Cited by 80 · see citing works
Suppression of Lung Tumor Formation by the Regulatory Subunit of Ribonucleotide Reductase
Gautam, A., & Bepler, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4462 · Cited by 80 · see citing works
Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agents
Elford, H. L., Riet, B. V., Wampler, G. L., Lin, A. L., & Elford, R. M. (1981) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(81)90014-5 · Cited by 80 · see citing works
Ribonucleotide Reductase Small Subunit M2B Prognoses Better Survival in Colorectal Cancer
Liu, X., Lai, L. L., Wang, X., Xue, L., Leora, S., Wu, J., Hu, S., Zhang, K., Kuo, M.-L., Zhou, L., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0054 · Cited by 66 · see citing works
Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase
Szekeres, T., Gharehbaghi, K., Fritzer, M., Woody, M. J., Srivastava, A., Riet, B. V., Jayaram, H. N., & Elford, H. L. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686113 · Cited by 61 · see citing works
Mice deficient for cytosolic thymidine kinase gene develop fatal kidney disease
Dobrovolsky, V. N., Bucci, T. J., Heflich, R. H., Desjardins, J. P., & Richardson, F. C. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(02)00224-x · Cited by 58 · see citing works
Ribonucleotide reductase as a chemotherapeutic target
Cory, J. G. (1988) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(88)90030-1 · Cited by 56 · see citing works
Aird, K. M., Li, H., Xin, F., Konstantinopoulos, P. A., & Zhang, R. (2013) · Cell Cycle · doi:10.4161/cc.26953 · Cited by 55 · see citing works
Self-citationFunctional Regulation of Mammalian Ribonucleotide Reductase
Elford, H. L. (1972) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(72)90004-0 · Cited by 54 · see citing works
Hydroxyurea (NSC-32065) in biologic fluids: dose-concentration relationship.
Beckloff, G. L., Lerner, H. J., Frost, D., Russo‐Alesi, F. M., & Gitomer, S. D. (1965) · PubMed · Cited by 51 · see citing works
Expression of p53R2 Is Related to Prognosis in Patients with Esophageal Squamous Cell Carcinoma
Okumura, H., Natsugoe, S., Yokomakura, N., Kita, Y., Matsumoto, M., Uchikado, Y., Setoyama, T., Owaki, T., Ishigami, S., & Aikou, T. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2416 · Cited by 50 · see citing works
Elevated Levels of Thymidylate Synthase Linked to Neoplastic Transformation of Mammalian Cells
Voeller, D. M., Rahman, L., & Zajac‐Kaye, M. (2004) · Cell Cycle · doi:10.4161/cc.3.8.1064 · Cited by 48 · see citing works
Gene Expression Analysis in Human Breast Cancer Associated Blood Vessels
Jones, D. T., Lechertier, T., Mitter, R., Herbert, J. M. J., Bicknell, R., Jones, J. L., Li, J., Buffa, F. M., Harris, A. L., & Hodivala‐Dilke, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044294 · Cited by 43 · see citing works
Yanamoto, S., Kawasaki, G., Yoshitomi, I., & Mizuno, A. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00588-8 · Cited by 39 · see citing works
GENETIC DEFECTS IN HUMAN PURINE AND PYRIMIDINE METABOLISM
Boss, G. R., & Seegmiller, J. E. (1982) · Annual Review of Genetics · doi:10.1146/annurev.ge.16.120182.001501 · Cited by 35 · see citing works
Uramoto, H., Sugio, K., Oyama, T., Hanagiri, T., & Yasumoto, K. (2006) · PubMed · Cited by 34 · see citing works
Xie, H., Jiang, W., Jiang, J., Wang, Y., Kim, R., Liu, X., & Liu, X. (2012) · Cancer · doi:10.1002/cncr.27715 · Cited by 31 · see citing works
Mannava, S., Moparthy, K., Wheeler, L. J., Leonova, K. I., Wawrzyniak, J. A., Bianchi, A., Berman, A. E., Flanagan, S. A., Shewach, D. S., Zeitouni, N. C., et al. (2012) · Aging · doi:10.18632/aging.100512 · Cited by 30 · see citing works
Management of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone-Induced Methemoglobinemia
Kunos, C. A., Radivoyevitch, T., Ingalls, S. T., & Hoppel, C. L. (2012) · Future Oncology · doi:10.2217/fon.11.147 · Cited by 30 · see citing works
Chromosomal Instability Triggered by Rrm2b Loss Leads to IL-6 Secretion and Plasmacytic Neoplasms
Chang, L., Guo, R., Huang, Q. M., & Yen, Y. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.040 · Cited by 28 · see citing works
A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma
Stadler, W. M., Desai, A. A., Quinn, D. I., Bukowski, R. M., Poiesz, B. J., Kardinal, C. G., Lewis, N. L., Makalinao, A., Murray, P., & Torti, F. M. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0524-6 · Cited by 27 · see citing works
Sridhar, S. S., Canil, C. M., Chi, K. N., Hotte, S. J., Ernst, S., Wang, L. E., Chen, E. X., Juhasz, A. N., Yen, Y., Murray, P., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1389-7 · Cited by 27 · see citing works
Chen, M., Rahman, L., Voeller, D. M., Kastanos, E. K., Yang, S. X., Feigenbaum, L., Allegra, C. J., Kaye, F. J., Steeg, P. S., & Zajac‐Kaye, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210273 · Cited by 26 · see citing works
Kunos, C. A., Radivoyevitch, T., Abdul‐Karim, F. W., Fanning, J., Abulafia, O., Bonebrake, A. J., & Usha, L. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-79 · Cited by 25 · see citing works
Wang, Q., Liu, X., Zhou, J., Huang, Y., Zhang, S., Shen, J., Loera, S., Yuan, X., Chen, W., Jin, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070191 · Cited by 25 · see citing works
Pešta, M., Kulda, V., Fiala, O., Šafránek, J., Topolčan, O., Krákorová, G., Cerny, R., & Pešek, M. (2012) · PubMed · Cited by 21 · see citing works
Electron transfer in N-hydroxyurea complexes with iron(III)
Nigović, B., Kujundžić, N., & Sanković, K. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.09.012 · Cited by 19 · see citing works
Leighl, N. B., Laurie, S. A., Chen, X. E., Ellis, P., Shepherd, F. A., Knox, J. J., Goss, G. D., Burkes, R. L., Pond, G. R., Dick, C., et al. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181a949b2 · Cited by 18 · see citing works
Matsushita, S., Ikeda, R., Fukushige, T., Tajitsu, Y., Gunshin, K., Okumura, H., Ushiyama, M., Akiyama, S., Kawai, K., Takeda, Y., et al. (2012) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.07.005 · Cited by 17 · see citing works
Purine Nucleotide Imbalance in Immunodeficiency Disorders
Ammann, A. J. (1985) · Springer eBooks · doi:10.1007/978-1-4613-2449-2_32 · Cited by 9 · see citing works
p53R2 expression as a prognostic biomarker in early stage non-small cell lung cancer
Hsu, N., Wu, J., Liu, X., Yen, Y., Chen, C., Chou, M., Lee, H., & Cheng, Y. (2010) · Oncology Letters · doi:10.3892/ol_00000108 · Cited by 8 · see citing works
Masahiko, M., Rey, D. A., & Cory, J. G. (1990) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(90)90008-p · Cited by 8 · see citing works
Flagged first, then by citations
2 of the 109 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Mechanisms and Regulation of Cellular Senescence
Roger, L., Tomas, F., & Gire, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313173 · Cited by 395 · see citing works
Biomarkers in Cancer Detection, Diagnosis, and Prognosis
Das, S., Dey, M. K., Devireddy, R. V., & Gartia, M. R. (2023) · Sensors · doi:10.3390/s24010037 · Cited by 445 · see citing works
Redox control of senescence and age-related disease.
Chandrasekaran, A., Idelchik, M. D. P. S., & Melendez, J. A. (2017) · Redox Biology · doi:10.1016/j.redox.2016.11.005 · Cited by 360 · see citing works
Advances in umami taste and aroma of edible mushrooms
Sun, L., Zhang, Z., Xin, G., Sun, B., Bao, X., Wei, Y., Zhao, X., & Xu, H. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.12.018 · Cited by 321 · see citing works
Tumor suppressor p53 and metabolism
Liu, J., Zhang, C., Hu, W., & Feng, Z. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy070 · Cited by 298 · see citing works
Critical Functions of the Lysosome in Cancer Biology
Davidson, S. M., & Heiden, M. G. V. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103101 · Cited by 209 · see citing works
Nucleotide imbalance decouples cell growth from cell proliferation
Diehl, F. F., Miettinen, T. P., Elbashir, R., Nabel, C. S., Darnell, A. M., Do, B. T., Manalis, S. R., Lewis, C. A., & Heiden, M. G. V. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00965-1 · Cited by 201 · see citing works
Deoxyribonucleotide metabolism, mutagenesis and cancer
Mathews, C. K. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3981 · Cited by 200 · see citing works
Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy
Wu, H., Gong, Y., Ji, P., Xie, Y., Jiang, Y.-Z., & Liu, G. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01263-x · Cited by 192 · see citing works
The role of lysosomes in cancer development and progression
Tang, T., Yang, Z., Wang, D., Yang, X., Wang, J., Li, L., Wen, Q., Gao, L., Bian, X., & Yu, S. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00489-x · Cited by 169 · see citing works
The lncRNA lincNMR regulates nucleotide metabolism via a YBX1 - RRM2 axis in cancer
Gandhi, M., Groß, M., Holler, J. M., Coggins, S. A., Patil, N., Leupold, J. H., Munschauer, M., Schenone, M., Hartigan, C. R., Allgayer, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17007-9 · Cited by 143 · see citing works
The SLX4 Complex Is a SUMO E3 Ligase that Impacts on Replication Stress Outcome and Genome Stability
Guervilly, J.-H., Takedachi, A., Naim, V., Scaglione, S., Chawhan, C., Lovera, Y., Despras, E., Kuraoka, I., Kannouche, P. L., Rosselli, F., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.11.014 · Cited by 137 · see citing works
Regulation of nucleotide metabolism in cancers and immune disorders
Ali, E. S., & Ben‐Sahra, I. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.03.003 · Cited by 131 · see citing works
Regulation of deoxynucleotide metabolism in cancer: novel mechanisms and therapeutic implications
Kohnken, R. A., Kodigepalli, K. M., & Wu, L. J. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0446-6 · Cited by 120 · see citing works
The roles of sirtuins family in cell metabolism during tumor development
Zhu, S., Dong, Z., Ke, X., Hou, J., Zhao, E., Zhang, K., Wang, F., Yang, L., Xiang, Z., & Cui, H. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.11.003 · Cited by 113 · see citing works
Robinson, A. D., Eich, M., & Varambally, S. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.11.013 · Cited by 104 · see citing works
Duan, Y., Xiong, D., Wang, Y., Zhang, Z., Li, H., Dong, H., & Zhang, J. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.143311 · Cited by 104 · see citing works
The FHIT gene product: tumor suppressor and genome “caretaker”
Waters, C. E., Saldivar, J. C., Hosseini, S. A., & Huebner, K. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1722-0 · Cited by 98 · see citing works
Suppression of p16 alleviates the senescence-associated secretory phenotype
(2021) · doi:10.18632/aging.202640 · Cited by 84 · see citing works
Self-citationDeoxyribonucleotide Triphosphate Metabolism in Cancer and Metabolic Disease
Buj, R., & Aird, K. M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00177 · Cited by 74 · see citing works
Self-citationThe roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi‐omics study
Xu, F., Guan, Y., Li, X., Zhang, P., Li, M., Gao, M., & Chong, T. (2021) · Cancer Medicine · doi:10.1002/cam4.4395 · Cited by 73 · see citing works
TOR coordinates nucleotide availability with ribosome biogenesis in plants
Busche, M., Scarpin, M. R., Hnasko, R. M., & Brunkard, J. O. (2021) · The Plant Cell · doi:10.1093/plcell/koab043 · Cited by 68 · see citing works
Emerging roles of nucleotide metabolism in cancer development: progress and prospect
Ma, J., Zhong, M., Xiong, Y., Gao, Z., Wu, Z., Liu, Y., & Hong, X. (2021) · Aging · doi:10.18632/aging.202962 · Cited by 66 · see citing works
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming
Buj, R., Chen, C., Dahl, E. S., Leon, K. E., Kuskovsky, R., Maglakelidze, N., Navaratnarajah, M., Zhang, G., Doan, M. T., Jiang, H., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.084 · Cited by 64 · see citing works
Self-citationMetabolic Reprogramming in Cancer is Induced to Increase Proton Production.
Sun, H., Zhou, Y., Skaro, M., Wu, Y.-R., Qu, Z.-X., Mao, F., Zhao, S.-W., & Xu, Y. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3392 · Cited by 54 · see citing works
Anacker, D. C., Aloor, H. L., Shepard, C., Lenzi, G. M., Johnson, B. A., Kim, B., & Moody, C. A. (2016) · Virology · doi:10.1016/j.virol.2016.09.028 · Cited by 60 · see citing works
Zhang, B., Hu, S., Baskin, E., Patt, A. C., Siddiqui, J., & Mathé, E. A. (2018) · Metabolites · doi:10.3390/metabo8010016 · Cited by 59 · see citing works
Metabolomics in bladder cancer: a systematic review.
Cheng, Y., Yang, X. F., Deng, X., Zhang, X., Li, P., Tao, J., Qin, C., Wei, J., & Lü, Q. (2015) · PubMed Central · Cited by 59 · see citing works
Xia, R., Wang, L., Xin, G., Bao, X., Sun, L., Xu, H., & Hou, Z. (2021) · LWT · doi:10.1016/j.lwt.2021.111176 · Cited by 54 · see citing works
Cellular senescence or stemness: hypoxia flips the coin
Otero-Albiol, D., & Carnero, A. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02035-0 · Cited by 53 · see citing works
SAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity
Mauney, C. H., & Hollis, T. (2018) · Autoimmunity · doi:10.1080/08916934.2018.1454912 · Cited by 50 · see citing works
Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion
Elliott, I. A., Dann, A. M., Xu, S., Kim, S. S., Abt, E. R., Kim, W., Poddar, S., Moore, A. M., Zhou, L., Williams, J. L., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812410116 · Cited by 50 · see citing works
Wang, J., Wu, P., Chen, P. C.-H., Lee, C.-W., Chen, W., & Hung, S. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0226 · Cited by 49 · see citing works
Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer
Song, N., Cui, K., Zeng, L., Li, M., Fan, Y., Shi, P., Wang, Z., Su, W., & Wang, H. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176357 · Cited by 48 · see citing works
IntLIM: integration using linear models of metabolomics and gene expression data
Siddiqui, J., Baskin, E., Liu, M., Cantemir-Stone, C. Z., Zhang, B., Bonneville, R., McElroy, J. P., Coombes, K. R., & Mathé, E. A. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2085-6 · Cited by 48 · see citing works
Liu, Y., Pan, J., Pan, X., Wu, L., Bian, J., Lin, Z., Xue, M., Su, T., Lai, S., Chen, F., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12577 · Cited by 48 · see citing works
Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics
Pal, S., Sharma, A. K., Mathew, S. P., & Jaganathan, B. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.955476 · Cited by 49 · see citing works
Craveiro, M., Cretenet, G., Mongellaz, C., Matias, M. I., Caron, O., de Lima, M. C. P., Zimmermann, V. S., Solary, É., Dardalhon, V., Dulić, V., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aal3024 · Cited by 46 · see citing works
Chi, C., Ronai, D., Than, M. T., Walker, C. J., Sewell, A. K., & Han, M. (2016) · Genes & Development · doi:10.1101/gad.275107.115 · Cited by 46 · see citing works
Metabolic alterations accompanying oncogene-induced senescence
Aird, K. M., & Zhang, R. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.963481 · Cited by 39 · see citing works
Self-citationDu, Y., Zhao, J., Teng, J., Ren, J., Shan, E., Zhu, X., Zhang, W., Wang, L., Hou, C., & Wang, Q. (2023) · Marine Pollution Bulletin · doi:10.1016/j.marpolbul.2023.115153 · Cited by 43 · see citing works
Gupta, I., Badrzadeh, F., Tsentalovich, Y. P., & Gaykalova, D. A. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03141-5 · Cited by 41 · see citing works
Muciño-Olmos, E. A., Vázquez-Jiménez, A., de León, U. A.-P., Matadamas-Guzman, M. L., Maldonado, V., López-Santaella, T., Hernández‐Hernández, A., & Reséndis-Antonio, O. (2020) · Scientific Reports · doi:10.1038/s41598-020-69026-7 · Cited by 39 · see citing works
Emerging methods and techniques for cancer biomarker discovery
Dakal, T. C., Dhakar, R., Beura, A., Moar, K., Maurya, P. K., Sharma, N. K., Ranga, V., & Kumar, A. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155567 · Cited by 39 · see citing works
Huang, C., Chang, P. M., Hsu, C.-W., Huang, C. F., & Ng, K. (2016) · BMC Bioinformatics · doi:10.1186/s12859-015-0845-0 · Cited by 36 · see citing works
Ballana, E., Badía, R., Terradas, G., Torres‐Torronteras, J., Ruiz, A., Pauls, E., Riveira‐Muñoz, E., Clotet, B., Martí, R., & Esté, J. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03145-14 · Cited by 35 · see citing works
The Dynamic Interplay between HIV-1, SAMHD1, and the Innate Antiviral Response
Antonucci, J. M., Gelais, C. S., & Wu, L. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01541 · Cited by 31 · see citing works
Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for Melanoma
Fatkhutdinov, N., Sproesser, K., Krepler, C., Liu, Q., Brafford, P. A., Herlyn, M., Aird, K. M., & Zhang, R. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0099 · Cited by 31 · see citing works
Self-citationLiu, Y., Wang, L., Xu, X., Yuan, Y., Zhang, B., Li, Z., Xie, Y., Yan, R., Zheng, Z., Ji, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019183118 · Cited by 29 · see citing works
Suganthagunthalam, D., Dinh, N.-T., Skolnick, J., & Styczynski, M. P. (2015) · Molecular BioSystems · doi:10.1039/c5mb00237k · Cited by 30 · see citing works
Hoffman, J. M., Tran, V., Wachtman, L. M., Green, C. L., Jones, D. P., & Promislow, D. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.01.007 · Cited by 29 · see citing works
Liu, Y., Wang, X., Li, Y., & Chen, X. (2018) · Aquatic Toxicology · doi:10.1016/j.aquatox.2018.03.006 · Cited by 30 · see citing works
An Overview of Molecular Cancer Pathogenesis, Prognosis, and Diagnosis
Cullen, J. M., & Breen, M. (2016) · Wiley eBooks · doi:10.1002/9781119181200.ch1 · Cited by 31 · see citing works
Fang, D., Wang, C., Deng, Z., Ma, N., Hu, Q., & Zhao, L. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110481 · Cited by 29 · see citing works
Understanding the interplay between dNTP metabolism and genome stability in cancer
Yagüe-Capilla, M., & Rudd, S. G. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.050775 · Cited by 30 · see citing works
Zhao, W., Wang, M., Wang, L., Liu, M., Jiang, K., Xia, S., Qi, C., & Wang, B. (2017) · Aquaculture · doi:10.1016/j.aquaculture.2017.11.044 · Cited by 28 · see citing works
Wang, Y., Wu, Y., Li, C., Zhao, Y., Xiang, H., Li, L., Yang, X., Chen, S., Sun, L., & Qi, B. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.851895 · Cited by 27 · see citing works
Comprehensive analysis of the ubiquitinome during oncogene-induced senescence in human fibroblasts
Bengsch, F., Tu, Z., Tang, H., Zhu, H., Speicher, D. W., & Zhang, R. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1026492 · Cited by 27 · see citing works
Self-citationA Metabolomics Pilot Study on Desmoid Tumors and Novel Drug Candidates
Mercier, K., Al‐Jazrawe, M., Poon, R. W. M., Acuff, Z., & Alman, B. A. (2018) · Scientific Reports · doi:10.1038/s41598-017-18921-7 · Cited by 27 · see citing works
Plamthottam, S., Sun, D. L., Valkenburgh, J. S. V., Valenzuela, J., Ruehle, B., Steele, D., Poddar, S., Marshalik, M., Hernandez, S., Radu, C. G., et al. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01675-0 · Cited by 25 · see citing works
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05495-y · Cited by 24 · see citing works
Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer
Wu, W., Zhao, Y., Qin, B., Jiang, X. M., Wang, C., Hu, R., Ma, R., Lee, M., Liu, H., Li, K., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104650 · Cited by 24 · see citing works
Apoptotic transition of senescent cells accompanied with mitochondrial hyper-function
Wang, D., Liu, Y., Zhang, R., Zhang, F., Sui, W., Chen, L., Zheng, R., Chen, X., Wen, F., Ouyang, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8536 · Cited by 24 · see citing works
Self-citationLi, X., Zheng, K., Hao, Y., & Tan, Z. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201607195 · Cited by 24 · see citing works
Pan, B., Hsu, C.-C., Wu, H., Chen, Y.-R., Zhou, X., Wang, S., Li, C., & Lin, H.-K. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01167-1 · Cited by 24 · see citing works
Nile, D. L., Rae, C. J., Walker, D. J., Waddington, J. C., Vincent, I. M., Burgess, K. E., Gaze, M. N., Mairs, R. J., & Chalmers, A. J. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00258-5 · Cited by 22 · see citing works
PAICS as a potential target for cancer therapy linking purine biosynthesis to cancer progression
Ma, A. H., & Xiong, X. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122070 · Cited by 22 · see citing works
Guglielmelli, P., Bisognin, A., Saccoman, C., Mannarelli, C., Coppe, A., Vannucchi, A. M., & Bortoluzzi, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140445 · Cited by 21 · see citing works
Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy
Castellví, M., Felip, E., Ezeonwumelu, I. J., Badía, R., García-Vidal, E., Pujantell, M., Gutiérrez-Chamorro, L., Teruel, I., Martínez‐Cardús, A., Clotet, B., et al. (2020) · Cancers · doi:10.3390/cancers12030713 · Cited by 21 · see citing works
Jacyna, J., Kordalewska, M., Artymowicz, M., Markuszewski, M., Matuszewski, M., & Matuszewski, M. (2022) · Cancers · doi:10.3390/cancers14051210 · Cited by 19 · see citing works
Control of Nucleotide Metabolism Enables Mutant p53’s Oncogenic Gain-of-Function Activity
Schmidt, V. A., Nagar, R., & Martinez, L. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122759 · Cited by 19 · see citing works
Loss of p16: A Bouncer of the Immunological Surveillance?
Leon, K. E., Tangudu, N. K., Aird, K. M., & Buj, R. (2021) · Life · doi:10.3390/life11040309 · Cited by 19 · see citing works
Self-citationYang, A., Wu, Q., Wang, A.-M., Chen, Q., Yang, J., Tao, Y., Sun, Y., & Zhang, J. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106229 · Cited by 18 · see citing works
Huldani, H., Malviya, J., Rodrigues, P., Hjazi, A. M., Deorari, M. M., Al‐Hetty, H. R. A. K., Qasim, Q. A., Alasheqi, M. Q., & Ihsan, A. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.3934 · Cited by 18 · see citing works
A new insight into cell biological and biochemical changes through aging
Sahabi, S., Jafari-Gharabaghlou, D., & Zarghami, N. (2022) · Acta Histochemica · doi:10.1016/j.acthis.2021.151841 · Cited by 16 · see citing works
Nieh, Y., Chou, Y., Chou, Y., Wang, C., Lin, S., Ciou, S., Yuh, C., & Wang, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147883 · Cited by 17 · see citing works
Alsaleh, M., Barbera, T. A., Reeves, H. L., Cramp, M., Ryder, S. D., Gabra, H., Nash, K. L., Shen, E. Y.-L., Holmes, E. C., Williams, R. L., et al. (2019) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s193996 · Cited by 16 · see citing works
Selenoproteins and the senescence-associated epitranscriptome
Lee, M. Y., Ojeda-Britez, S., Ehrbar, D. J., Samwer, A., Begley, T. J., & Melendez, J. A. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221116592 · Cited by 15 · see citing works
Commonalities in Metabolic Reprogramming between Tobacco Use and Oral Cancer
Rushing, B. R., Tilley, S., Molina, S., Schroder, M., & Sumner, S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191610261 · Cited by 14 · see citing works
Kafer, G. R., & Cesare, A. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00416 · Cited by 12 · see citing works
Mlak, R., Powrózek, T., Brzozowska, A., Homa‐Mlak, I., Mazurek, M., & Malecka-Massalska, T. J. (2018) · Cancer Biomarkers · doi:10.3233/cbm-171082 · Cited by 13 · see citing works
Chromosomal instability causes sensitivity to protein folding stress and ATP depletion
Khan, M., Shaukat, Z., Saint, R. B., & Gregory, S. L. (2018) · Biology Open · doi:10.1242/bio.038000 · Cited by 13 · see citing works
The cGAS/STING signaling pathway: a cross-talk of infection, senescence and tumors
Zeng, P.-H., & Yin, W.-J. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2109899 · Cited by 12 · see citing works
Zhao, J., Wang, W., Liu, T., Zhang, L., Lin, D., Yao, J., Peng, X., Jin, G., Ma, T.-T., Gao, J., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-10354-4 · Cited by 12 · see citing works
Lysosomes, curcumin, and anti-tumor effects: how are they linked?
Shen, Q., Pan, X., Li, Y., Li, J., Zhang, C.-L., Jiang, X.-C., Liu, F., & Pang, B. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1220983 · Cited by 12 · see citing works
Acetate drives ovarian cancer quiescence via ACSS2-mediated acetyl-CoA production
Sharrow, A. C., Megill, E., Chen, A. J., Farooqi, A., Tangudu, N. K., Uboveja, A., McGonigal, S. C., Hempel, N., Snyder, N. W., Buckanovich, R. J., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102031 · Cited by 11 · see citing works
Self-citationMulti-omics analysis defines 5-fluorouracil drug resistance in 3D HeLa carcinoma cell model
Wang, L., Wang, X., Wang, T., Zhuang, Y., & Wang, G. (2021) · Bioresources and Bioprocessing · doi:10.1186/s40643-021-00486-z · Cited by 11 · see citing works
De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression
Tangudu, N. K., Buj, R., Wang, H., Wang, J., Cole, A. R., Uboveja, A., Fang, R. S., Amalric, A., Yang, B., Chatoff, A. G., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0450 · Cited by 13 · see citing works
Self-citationThymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survival
Vijayakurup, V., Maeng, K., Lee, H. S., Meyer, B. S., Burkett, S. S., Nawab, A., Dougherty, M. W., Jobin, C., Mahmud, I., Garrett, T. J., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.147417 · Cited by 10 · see citing works
Novel GIRlncRNA Signature for Predicting the Clinical Outcome and Therapeutic Response in NSCLC
Zhang, Q., Liu, X., Chen, Z., & Zhang, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.937531 · Cited by 9 · see citing works
Highly Specific Recognition of Guanosine Using Engineered Base‐Excised Aptamers
Li, Y., & Liu, J. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202001835 · Cited by 9 · see citing works
Human Mitochondrial Protein HSPD1 Binds to and Regulates the Repair of Deoxyinosine in DNA
Zheng, X., Chang, S., Liu, Y., Dai, X., & You, C. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00854 · Cited by 8 · see citing works
Wang, J., Liu, L., Long, Q., Bai, Q., Xia, Y., Xi, W., Xu, J., & Guo, J. (2017) · Oncology Letters · doi:10.3892/ol.2017.6362 · Cited by 8 · see citing works
Li, X., Zheng, K., Hao, Y., & Tan, Z. (2016) · Angewandte Chemie · doi:10.1002/ange.201607195 · Cited by 8 · see citing works
Zhou, C., Liu, Y., Liu, H., Lü, J., Zhang, B., Zhu, L., Wang, S., Lei, H.-M., & Han, B. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07992-4 · Cited by 6 · see citing works
Zhong, W., Ma, L., Yang, F., Cao, J., Tan, J., & Li, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1027441 · Cited by 6 · see citing works
DNA repair and replicative stress addiction in neuroblastoma
Durinck, K., & Irwin, M. S. (2024) · EJC Paediatric Oncology · doi:10.1016/j.ejcped.2024.100177 · Cited by 5 · see citing works
Beasy, G., Bernuzzi, F., Day-Walsh, P. E., Tronsco‐Rey, P., Defernez, M., Saha, S., Mithen, R. F., Τράκα, Μ., & Kroon, P. A. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70008 · Cited by 5 · see citing works
Metabolic Regulator IAPP (Amylin) Is Required for BRAF and RAS Oncogene-Induced Senescence
Garnett, S., de Bruyns, A., Provencher-Tom, V., Dutchak, K., Shu, R., & Dankort, D. L. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0879 · Cited by 5 · see citing works
Shewanella phage encoding a putative anti-CRISPR-like gene represents a novel potential viral family
Wang, H.-Y., Zheng, K., Wang, M., Ma, K., Ren, L., Guo, R., Ma, L., Zhang, H., Liu, Y., Xiong, Y., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.03367-23 · Cited by 5 · see citing works
- Authors
- Aird, K. M., & Zhang, R.
- Affiliations
- The Wistar Institute (US)
- Corresponding author
- Zhang, Rugang
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 356
- Issue
- 2
- Pages
- 204-210
- ISSN
- 0304-3835 (ISSN-L)
- PMC
- PMC4115046
- OpenAlex
- W1974913955
- Cited by
- 166
- References
- 109
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 31 · 2023: 17 · 2022: 22 · 2021: 17 · 2020: 11 · 2019: 10 · 2018: 11 · 2017: 6 · 2016: 12 · 2015: 6 · 2014: 4
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Letters (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA010815, T32CA9171-35, R01CA160331, R01CA163377, T32CA009171, P30CA010815)
- Ovarian Cancer Academy
- Topics
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- oncogene-induced senescence, nucleotide metabolism, dNTP pools, DNA replication, DNA damage response, tumor suppression, tumor progression, cellular senescence, cancer therapy, DNA repair
- MeSH terms
- Cell Transformation, Neoplastic, Deoxyribonucleotides, DNA Damage, DNA Repair, DNA Replication, Humans, Neoplasms, Oncogenes, Biomarkers, Tumor, Neoplastic Stem Cells, Signal Transduction, Cellular Senescence, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review